Provided by Tiger Fintech (Singapore) Pte. Ltd.

SOLSTICE MINERALS LTD

0.190
+0.0052.70%
Volume:264.00
Turnover:50.00
Market Cap:19.66M
PE:4.51
High:0.190
Open:0.190
Low:0.190
Close:0.185
Loading ...

Sellas Life Sciences Says Group Data Show Tambiciclib Tops Benchmark for Median Overall Survival in Leukemia Study; Shares Up

MT Newswires Live
·
08 Apr

Solstice Minerals Starts Air Core Drilling at Western Australia Prospect; Shares Up 3%

MT Newswires Live
·
26 Mar

Solstice Minerals Says Resampling at Western Australia Gold Project Confirms Intercepts

MT Newswires Live
·
17 Mar

Solstice Minerals Fiscal H1 Loss Narrows

MT Newswires Live
·
11 Mar

Cyprium Metals Completes Sale of Western Australia Project; Shares Rise 5%

MT Newswires Live
·
07 Mar

Solstice Minerals Completes Acquisition of Western Australia Project; Shares Rise 6%

MT Newswires Live
·
06 Mar

3 ASX Penny Stocks With Market Caps Over A$10M To Watch

Simply Wall St.
·
19 Feb

Solstice Minerals Completes Step-Out Drilling at Western Australia Project; Shares Fall 6%

MT Newswires Live
·
10 Feb

Solstice Minerals Acquires Western Australia Copper-Gold Project From Cyprium Metals

MT Newswires Live
·
05 Feb

BUZZ-Australia's Solstice Minerals gains on buying copper project

Reuters
·
05 Feb

Solstice Minerals enters rising copper market with strategic Nanadie project acquisition

Small Caps
·
05 Feb

BRIEF-Solstice Minerals To Acquire Nanadie Copper-Gold Project

Reuters
·
05 Feb

Solstice Minerals - Sale and Purchase Agreement With Cyprium Metals

THOMSON REUTERS
·
05 Feb

Solstice Minerals Ltd - to Acquire Nanadie Copper-Gold Project

THOMSON REUTERS
·
05 Feb

SELLAS Life Sciences Shares Fall; Interim Trial Results on Acute Myeloid Leukemia Treatment Issued

MT Newswires Live
·
24 Jan

ASX Small-Cap Stocks to Watch

MT Newswires Live
·
20 Jan

ASX Small-Cap Stocks to Watch

MT Newswires Live
·
06 Jan

Sims Lifecycle Services Listed as a Representative Vendor in the 2024 Gartner® "Market Guide for IT Asset Disposition"

Business Wire
·
22 Nov 2024

SELLAS Life Sciences Gets FDA Rare Pediatric Disease Designation for Acute Myeloid Leukemia Immunotherapy

MT Newswires Live
·
15 Oct 2024